Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea M Collins

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|October 20, 2020
Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial PneumoniaShampa Das, Richard Fitzgerald, Asad Ullah, et al.
American Journal of Respiratory and Critical Care Medicine|February 2, 2013
Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adultsDaniela M Ferreira, Daniel R Neill, Mathieu Bangert, et al.
The Journal of Infectious Diseases|January 29, 2019
Pneumococcal Colonization in Healthy Adult Research Participants in the Conjugate Vaccine Era, United Kingdom, 2010-2017Hugh Adler, Elissavet Nikolaou, Katherine Gould, et al.
BMJ Open|January 10, 2024
Serotype 3 Experimental Human Pneumococcal Challenge (EHPC) study protocol: dose ranging and reproducibility in a healthy volunteer population (challenge 3)Phoebe Hazenberg, Ryan E Robinson, Madlen Farrar, et al.
The New England Journal of Medicine|December 29, 2023
Nirsevimab for Prevention of Hospitalizations Due to RSV in InfantsSimon B Drysdale, Katrina Cathie, Florence Flamein, et al.
Wellcome Open Research|September 2, 2024
A feasibility study of controlled human infection with intradermal Bacillus Calmette-Guérin (BCG) injection: Pilot BCG controlled human infection modelEmma Carter, Ben Morton, Dima ElSafadi, et al.
Cell Host & Microbe|August 24, 2024
RSV and rhinovirus increase pneumococcal carriage acquisition and density, whereas nasal inflammation is associated with bacterial sheddingElena Mitsi, Elissavet Nikolaou, Andre Goncalves, et al.
The Lancet. Child & Adolescent Health|May 16, 2025
180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trialAlasdair P S Munro, Simon B Drysdale, Katrina Cathie, et al.
Scientific Reports|September 15, 2021
The nose is the best niche for detection of experimental pneumococcal colonisation in adults of all ages, using nasal washElissavet Nikolaou, Esther L German, Annie Blizard, et al.
Mucosal Immunology|July 1, 2024
Inflammation of the nasal mucosa is associated with susceptibility to experimental pneumococcal challenge in older adultsBritta C Urban, André N A Gonçalves, Dessi Loukov, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|October 20, 2020
Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial PneumoniaShampa Das, Richard Fitzgerald, Asad Ullah, et al.
American Journal of Respiratory and Critical Care Medicine|February 2, 2013
Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adultsDaniela M Ferreira, Daniel R Neill, Mathieu Bangert, et al.
The Journal of Infectious Diseases|January 29, 2019
Pneumococcal Colonization in Healthy Adult Research Participants in the Conjugate Vaccine Era, United Kingdom, 2010-2017Hugh Adler, Elissavet Nikolaou, Katherine Gould, et al.
BMJ Open|January 10, 2024
Serotype 3 Experimental Human Pneumococcal Challenge (EHPC) study protocol: dose ranging and reproducibility in a healthy volunteer population (challenge 3)Phoebe Hazenberg, Ryan E Robinson, Madlen Farrar, et al.
The New England Journal of Medicine|December 29, 2023
Nirsevimab for Prevention of Hospitalizations Due to RSV in InfantsSimon B Drysdale, Katrina Cathie, Florence Flamein, et al.
Wellcome Open Research|September 2, 2024
A feasibility study of controlled human infection with intradermal Bacillus Calmette-Guérin (BCG) injection: Pilot BCG controlled human infection modelEmma Carter, Ben Morton, Dima ElSafadi, et al.
Cell Host & Microbe|August 24, 2024
RSV and rhinovirus increase pneumococcal carriage acquisition and density, whereas nasal inflammation is associated with bacterial sheddingElena Mitsi, Elissavet Nikolaou, Andre Goncalves, et al.
The Lancet. Child & Adolescent Health|May 16, 2025
180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trialAlasdair P S Munro, Simon B Drysdale, Katrina Cathie, et al.
Scientific Reports|September 15, 2021
The nose is the best niche for detection of experimental pneumococcal colonisation in adults of all ages, using nasal washElissavet Nikolaou, Esther L German, Annie Blizard, et al.
Mucosal Immunology|July 1, 2024
Inflammation of the nasal mucosa is associated with susceptibility to experimental pneumococcal challenge in older adultsBritta C Urban, André N A Gonçalves, Dessi Loukov, et al.
Pageof 6